Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bulevirtide (4 trials)
entecavir (baraclude) (1 trial)
interferon alpha-2a (roferon-a) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
pegylated-interferon (1 trial)
tenofovir (viread) (1 trial)
Hepatitis (Phase 3)
Hepatitis A (Phase 2)
Hepatitis B (Phase 2)
Hepatitis B, Chronic (Phase 2)
Hepatitis, Chronic (Phase 2)
Hepatitis D (Phase 3)
Hepatitis D, Chronic (Phase 3)
Infections (Phase 2)
Trials (6 total)
Trial APIs (6 total)